Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 01, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 49,305 $ 18,767
Accounts receivable, net 9,745 6,406
Inventory, net 112,364 136,026
Other current assets 7,183 6,672
Total current assets 178,597 167,871
Property and equipment, net 24,423 24,290
Right-of-use - assets - operating leases, net 22,850 23,951
Right-of-use - assets - finance leases, net 18,401 19,750
Other non-current assets 2,589 2,537
Total assets 246,860 238,399
Current liabilities:    
Accounts payable 55,221 57,616
Accrued expenses 20,924 16,466
Right-of-use - obligation - operating, current 4,640 4,571
Right-of-use - obligation - finance, current 4,601 4,753
Other current liabilities 6,071 4,622
Total current liabilities 91,457 88,028
Right-of-use - obligation - operating, non-current 20,306 21,412
Right-of-use - obligation - finance, non-current 14,826 15,916
Other non-current liabilities 3,202 2,971
Total liabilities 129,791 128,327
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.001 par value; 100,000 shares authorized; 54,693 and 52,960 shares issued and outstanding as of December 31, 2022 and January 1, 2022 (of which 2,565 are treasury stock) 59 57
Treasury stock (7,625) (7,625)
Additional paid-in capital 303,185 297,265
Accumulated other comprehensive income 1,150 1,126
Accumulated deficit (179,700) (180,751)
Total stockholders' equity 117,069 110,072
Total liabilities and stockholders' equity $ 246,860 $ 238,399